赛伦生物(688163.SH)发布前三季度业绩，归母净利润6421万元，同比增长2.01%

Core Insights - Sirun Biotech (688163.SH) reported a revenue of 175 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 1.07% [1] - The company's net profit attributable to shareholders reached 64.21 million yuan, marking a year-on-year increase of 2.01% [1] - The adjusted net profit was 56.44 million yuan, showing a year-on-year growth of 12.15% [1] - Basic earnings per share stood at 0.59 yuan [1]